Advertise on podcast: Talking Rheumatology Research

In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice!   Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica? In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelian randomisation study. They cover the key findings, which include some novel loci and potential therapeutic targets for PMR, as well as the hallmarks of a good Mendelian randomisation study.  Further reading: Read Steven's full study in Rheumatology Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

How can we improve time from symptom onset to axSpA diagnosis? In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated referral and education system. They discuss the importance of a multi-pronged approach to education, as well as how clinicians might start improving time to axSpA diagnosis in their own settings.  Further reading:  Read Antoni's full article in Rheumatology Advances in PracticeFind out more about the Act on Axial SpA campaignAccess the axSpA symptom checker Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Should there be distinct definitions for difficult-to-treat and complex-to-manage psoriatic arthritis? In this episode of Talking Rheumatology Research, Dr Fabian Proft and Dr Andre Ribeiro join Dr Ai Lyn Tan to discuss their work to define difficult-to-treat psoriatic arthritis, as part of GRAPPA's wider D2T-PsA project.  Find out more:  Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals Find out more about GRAPPA and its work Keywords: psoriatic arthritis, PSA, difficult-to-treat, D2T, complex-to-manage, C2M, GRAPPA, rheumatology.  Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients.  Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition. You can read this article [https://doi.org/10.1093/rheumatology/kead604] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Peter Boyd and Ingrid de Groot join Dr. Latika Gupta to explore the value of patient involvement in Rheumatology research. Reflecting on their lived experience, Peter and Ingrid discuss their proudest moments, and identify areas in the patient and physician partnership that they hope to improve in the future. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Recorded at #BSR24, Richard P Beesley joins Dr Ai Lyn Tan to discuss his recent article, which measured the level of community awareness in the UK that children and young people can develop arthritis. Listen now to hear about what you can do to help raise awareness of childhood arthritis, and why this is so important. You can read this article [https://doi.org/10.1093/rap/rkad099] in Rheumatology Advances in Practice. Keywords: Juvenile idiopathic arthritis, arthritis, awareness, communication Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

In this fascinating episode recorded at #BSR24, Dr Melanie Sloan joins Prof Ernest Choy to discuss the latest results from the INSPIRE study, which seeks to understand neuropsychiatric symptom prevalence and impact in people with systemic autoimmune rheumatic diseases (SARDs).  Dr Melanie Sloan is a researcher in the Department of Public Health and Primary Care at the University of Cambridge. Her research focuses on improving patient-clinician relationships, as well as trialling interventions for patients with SARDs.   Want to find out more about Melanie’s research? Here’s your further reading list:  Prevalence and identification of neuropsychiatric symptoms in SARDs Neuropsychiatric symptoms in lupusAttribution of neuropsychiatric symptoms and prioritisation of evidence in lupusProdromal neuropsychiatric symptoms in lupus Keywords: autoimmune diseases, lupus, rheumatology, nightmares, daymares, mental health, psychosis, communication.  Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients. Listen now to hear about the current technological developments and what this means for future clinical practice!  You can read this article [https://doi.org/10.1093/rheumatology/kead534] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab. Listen now to hear the findings and what this means for future clinical practice!  You can read this article [https://doi.org/10.1093/rheumatology/kead457] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology. Want to read more? Here's your further reading list: 1. Read Christina and Isabella's full paper 2. Read Latika's work on the gender gap in journal Editorial Boards Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see.  Ernest will take the reins from Dr Marwan Bukhari (Royal Lancaster Infirmary), who finishes his highly productive term as Editor-in-Chief in February 2024. Want to discuss a potential article? Email [email protected].  Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a consultant rheumatologist based at University College London. Managed by the University of Manchester, the UK JIA Biologics Register is a collaboration between BSR and Versus Arthritis that measures the safety and effectiveness of biologic and biosimilar treatment for juvenile idiopathic arthritis.   Want to find out more? Here's your further reading list: 1. Read Lianne and Coziana's full paper 2. Find out more about the UK JIA Biologics Register 3. Explore research from the BSR biologics registers  Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDMARD-IR). Listen now to hear the findings and what this means for future clinical practice!  You can read this article [https://doi.org/10.1093/rheumatology/keac605] in Rheumatology. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination. Listen now to hear the findings, and what this means for future clinical practice and the impact on RA patients at risk for poor functional and radiological outcomes. You can read this article [https://doi.org/10.1093/rap/rkad048] in Rheumatology Advances in Practice. Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.